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z.2013.05Abstract Cyclosporine A (CsA), a potent immunosuppressive agent, has several adverse effects on
different organs including the spleen. Fucoidan is a sulfated polysaccharide extracted from marine
algae and it has numerous biological activities. The present study aimed to investigate the adverse
effects of CsA on the spleen of rats and to evaluate the role of fucoidan, as immune-modulator and
antioxidant substance, in the treatment of the CsA adverse effects. CsA administration to rats
caused some histological degenerated changes in lymphocytes, plasma cells and neutrophils as well
as it caused a reduction in CD3+ T cell expression in the spleen and in IL-2, IL6-, IFN-c, IgM and
IgG levels in the plasma. The histological degeneration was ameliorated by fucoidan treatment in
variable degrees. CD3+ T cell expression and the plasma levels of IL-2, IL-6 and IFN-c were
increased by fucoidan treatment. IgM had more inhibition by fucoidan but IgG was improved.
Lipid peroxidation was increased by CsA and fucoidan failed to reverse this change. Nitric oxide
was increased by the high dose of CsA and was decreased after treatment with fucoidan. Glutathi-
one was increased by fucoidan treatment. Superoxide dismutase activity was inhibited by CsA and
low dose of fucoidan improved this inhibition. In conclusion CsA exerted adverse effects on the2325339; fax: +20 882342708.
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244 Hossam El-Din M. Omar et al.spleen tissue as shown by histological and biochemical changes. Fucoidan has immune-modulatory
and antioxidant effects against CsA-induced adverse effects on the spleen tissue.
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Cyclosporine A (CsA), a lipophilic drug, is a metabolic cyclic
polypeptide of the fungus Tolypocladium inﬂatum and is widely
used in allograft rejection and in the treatment of autoimmune
diseases (Borel et al., 1976; Kapturczak et al., 2004). It has po-
tent immunosuppressive properties through blockage of some
cytokine gene transcription in activated T cells. CsA inhibits
the phosphatase activity of calcineurin, thereby preventing
the nuclear factor of activated T cell (NFAT) activation (Hall-
oran, 1996; Allison, 2000; Gregory, 2000). NFAT activation
and nuclear translocation are required for the transcription of
many cytokines particularly interleukin-2 (IL-2), which is nec-
essary for the proliferation and maturation of T cells. More-
over, CsA enhances the expression of transforming growth
factor-b (TGF-b) (Salom et al., 1993; Halloran, 1996; Gregory,
2000) and blocks the activation of C-Jun N terminal kinases
and p38 signaling pathways, that makes it a highly speciﬁc
inhibitor of T cell activation (Allison, 2000). Despite the thera-
peutic beneﬁts of CsA as immunosuppressant, it has adverse
toxicity effects (De Mattos et al., 2000; Yoon and Yang,
2009) which are mediated by increases of the reactive oxygen
species and a decrease of the activities of antioxidant enzymes
(SOD, CAT and GPx) (Al-Malki, 2011). In addition, lym-
phoma and squamous cell carcinoma have been noted in CsA
treated animal (Blackwood et al., 2004; Callan et al., 2005).
CsA binds to cyclophilin to form an active complex which
inhibits calcineurin phosphatase enzyme and increase cytosol
Ca2+. The higher cytosolic Ca2+ level in activated lympho-
cytes causes an increase in their susceptibility to oxidative
stress-induced cell death (Degasperi et al., 2008). In addition,
CsA has a direct oxidative effect on human B cells and these
effects are blocked by the antioxidants (Chen et al., 2001).
Thymus in CsA treated animal showed a very marked deple-
tion of the medullary zones as well as the histiocytes contain-
ing cellular debris appeared. However, the most prominent
feature in the spleen of CsA treated animal was the loss of lym-
phocytes within the periarteriolar sheaths and marginal zones
that resulted in marked reduction in these zones (Blair et al.,
1982; Masri et al., 1988), whereas the reduction in cellular den-
sity of the periarteriolar sheaths was higher than the reduction
in the marginal zones (Armas et al., 1989).
Fucoidan, a sulfated polysaccharide of brown algae, is po-
tent anticoagulant, antitumor, antiviral and immunomodula-
tor (Maruyama et al., 2003; Chabut et al., 2004; Lee et al.,
2004). One mechanism by which the fucoidan exerts its immu-
nomodulatory effect is provided by the abundant supply of fu-
cose (http://www.agelsingapore.info, 2012). Fucoidan protects
bone marrow cells from radiation (Byon et al., 2008), inhibits
selectin-mediated adhesion of hematopoietic progenitor cells
(Frenette and Weiss, 2000). Also, fucoidan modulates the func-
tion of various immune cells such as neutrophils (Zen et al.,
2002), lymphocytes (Oomizu et al., 2006), natural killer (NK)
cells (Maruyama et al., 2006), and dendritic cells (DCs) (Kim
and Joo, 2008). The antitumor activity of fucoidan is relatedto the activation of macrophage-mediated tumor cell killing
as well as fucoidan interferes cancer cell metastasis by inhibit-
ing the physical interaction between the tumor cell and base-
ment membrane (Jiao et al., 2011). Moreover, fucoidan
enhances the phagocytic activities of macrophages with signif-
icant increases in the production of NO, H2O2, TNF-a, and
IL-6 (Choi et al., 2005). Also, fucoidan has a great potential
in preventing free radical synthesis that mediated diseases
and it can prevent the increase of lipid peroxide in the serum,
liver and spleen of diabetic mice (Li et al., 2002). In light of the
above, the present study was intended to investigate the ad-
verse toxicity of CsA on the spleen of male albino rats and
to evaluate the role of fucoidan as immunomodulator and
antioxidant in the treatment of CsA adverse toxicities.
Material and methods
Experimental protocol
Animals
Forty adult male albino rats weighing 200–250 g were used in
this study. Rats were purchased from the Animal House of
the Faculty of Medicine, Assuit University. Rats were housed
in cages and were kept in a room temperature (30 ± 5 C) with
normal 12 h light/12 h dark cycle. They had ad libitum access to
pelleted diet and water throughout the study. The experiment
was carried-out in accordance with the national regulations
on animal welfare and Institutional Animal Ethical Committee.
Chemicals
Cyclosporine, Neoral Oral Solution (cyclosporine oral solu-
tion, USP) MODIFIED. It is present as a clear, yellow liquid
supplied in 50 ml bottles containing 100 mg/ml (NDC 0078-
0274-22). It is distributed by Novartis Pharmaceuticals Corpo-
ration, East Hanover, New Jersey 07936. Fucoidan from Fucus
vesiculosus, was purchased from Sigma Chemicals, St. Louis,
MO, USA. Primary antibody for CD3+ and the secondary
kit for the immunohistochemistry technique were obtained
from Abcam Company (Abcam PLC, 204 and 330 Cambridge
Science Park, UK). ELISA kits for quantitative measurements
of Rat IL-2, IL-6, INF- c, IgG and IgM levels in plasma in
sandwich ELISA format were obtained from Koma Company
(Koma Biotech INC., 1487, Gayang-don, Gangseao-gu, Seoul,
South Korea). All others chemicals and reagents were of the
highest purity commercially available.
Experimental protocol
The rats were randomly divided into ﬁve groups, eight rats
each:
(1) Group I (Control) was treated with olive oil (2 ml/
kg b.w.) and saline (2 ml/kg b.w.) for 20 days.
(2) Group II was treated orally with CsA (25 mg/kg b.w.),
dissolved in olive oil, daily for 20 days according to Jose-
phine et al. (2009).
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dissolved in olive oil, concomitant with subcutaneous
treatment with fucoidan (5 mg/kg b. w.), daily for
20 days according to Veena et al. (2006).
(4) Group IV was treated orally with CsA (50 mg/kg b. w.)
according to Al-Malki and Moselhy (2010) for 10 days
and left for recovery for another 10 days.
(5) Group V was treated orally with CsA (50 mg/kg b. w.)
for 10 days then treated subcutaneously with fucoidan
(10 mg/kg) according to Rhee and Lee (2011) daily for
another 10 days.Collecting of sample
After the experiment period (20 days) rats of different groups
were anesthetized by ether and scariﬁed by cervical dislocation.
Blood was collected into a sterilized tube containing EDTA for
ELISA study. For biochemical studies, spleen tissues were
quickly removed, washed in (0.1 M) phosphate buffer (pH
7.4) and then stored at 20 C. Pieces of spleen were quickly
removed and ﬁxed immediately in 10% neutral buffered for-
malin for histological and CD3 T cell immunohistochemical
studies and some pieces were ﬁxed in 4% cold glutaraldehyde
for semithin and ultra structure studies.
Semithin and transmission electron microscopy
Spleen specimens ﬁxed in gluteraldehyde (5%) were trained and
approximately 1 · 1 · 1 mm blocks were prepared. These
blocks were washed in cacodylate buffer (0.1 M, pH 7.2) for
1–3 h and then post ﬁxed in 1% osmium tetraoxide for 2 h.
After repeated washing in cacodylate buffer and dehydration
in ascending grades of ethyl alcohol up to 100%, the specimens
were ﬁrst placed in propylene oxide for 60 min, then in pure
epon 812 and incubated in a special polymerization incubator
(ﬁrst day at 35 C, second day at 45 C and third day at
60 C). The blocks were trimmed with LKB ultratom. Semithin
sections were stained with toluidine blue (T.B.) for 2 min at
80 C and examined by light microscope. Representative ﬁelds
of semithin sections were selected. Ultrathin sections (70 nm)
were cut with a diamond knife using a Reichert OMVs ultrami-
crotome. They were mounted in copper grids and stained with
uranyl acetate lead citrate stain. The ultrastructural investiga-
tion was carried out with Transmission electron microscope
(TEM) (Joel Cx II) according to Bancroft and Stevens (1982).
Immunohistochemical studies
For the immunohistochemical study, primary antibody for
CD3+ and secondary kit for the immunohistochemistry tech-
nique were obtained from Abcam Company. Parafﬁn sections
of 5 lm thickness were prepared and the staining was per-
formed using labeled Streptavidin–Biotin immunoperoxidase
technique according to the manufacturer’s instructions.
Splenic tissue homogenate and plasma preparation
10% w/v homogenate of each spleen tissue was prepared by
homogenized 500 mg of the spleen in 5 ml (0.1 M) phosphate
buffer (pH 7.4) using homogenizer (IKA Yellow line DI 18
Disperser, Germany) and kept frozen at 20 C for the subse-
quent biochemical assay. Blood samples were centrifuged at
4000 rpm for 10 min to separate the plasma and were kept fro-
zen at 20 C.Cytokine and Immunoglobulin assay
The IL-2, IL-6, INF-c, IgM and IgG levels in plasma were
quantity measured by the ELISA method according to the
manufacturer’s instructions. In brief, sandwich ELISAs utilize
multiple-well microtiter plates, coated with capture antibodies,
to capture soluble proteins. The bound proteins are then de-
tected with a subsequent detection antibody, which is typically
labeled with an enzyme or biotinylated, then followed with
streptavidin-enzyme conjugate. A colorimetric substrate is
then added, which results in a color change based on the
amount of antigen captured. By using a plate reader and plot-
ting resulting values on a standard curve, precise, quantitative
values can be obtained.
Oxidative stress biomarker determination
Lipid peroxidation products as TBARS content were deter-
mined according to the method of Ohkawa et al. (1979). NO
content was measured as nitrate concentration colorimetrically
using the method of Ding et al. (1988). Glutathione (GSH)
content was determined using the method of Beutler et al.
(1963). Vitamin C content was measured as described by Jago-
ta and Dani (1982). The activity of superoxide dismutase
(SOD) was determined basing on its ability to inhibit the
autoxidation of epinephrine at alkaline medium according to
the method of Misra and Fridovich (1972). The activity of cat-
alase (CAT) was determined basing on its ability to decompose
H2O2 to H2O and O2 according to Beers and Sizer (1952).
Glucose 6 phosphate dehydrogenase (G6PD) activity was
determined basing on its ability to reduce NADP according
to the method of Tsai and Chen (1998). Protein content in
the spleen tissues was determined by the method of Lowry
et al. (1951).
Statistical analysis
The results were analyzed by one way analysis of variance
(ANOVA) followed by Newman–Keuls Multiple Comparison
Test as post-Test by using Prism program for windows, version
3.0 (Graph pad software, Inc., San Diago CA. USA). The Sig-
niﬁcance difference between groups was accepted at P< 0.05,
<0.001 and <0.001.
Results
Semithin section observation
Pathological examination of a semithin section of the spleen in
the control group showed a normal histological structure in the
form of healthy lymphocytes, reticulum cells and splenic arteri-
ole (Fig. 1A). In group II, many degenerated lymphocytes with
pyknotic nuclei were noticed (Fig. 1B). In group III, a few
degenerated lymphocytes and reticulum cells were seen
(Fig. 1C). In group IV, the numbers of degenerated lympho-
cytes were numerous (Fig. 1D). In group V, the lymphocytes,
reticulum cells and mast cells were more or less normal as well
as a few of apoptotic and necrotic cells were observed (Fig. 1E).
Transmission electron microscope observation
With transmission electron microscopy the spleen in group I
showed normal healthy looking lymphocytes, plasma cells
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Fig. 1 A semithin section of the spleen from the (A) control group showing normal healthy lymphocyte (arrow), reticulum cells (RC) and
splenic arteriole (asterisk). (B) Group II showing many degenerated lymphocytes with pyknotic nuclei (arrows). (C) Group III showing few
degenerated lymphocytes (arrow), reticulum cells (RC). (D) Group IV showing increase in the number of degenerated lymphocytes
(arrows), (E) group V showing normal lymphocyte (L), reticulum cell (RC) and mast cell (asterisk). Apoptotic and necrotic cells (arrows)
are observed. Toulidine blue stain, (X 1000).
246 Hossam El-Din M. Omar et al.and dendritic cells (Fig. 2A). In group II degenerated plasma
cells were seen, some cells appeared as ghost and others
showed a marked dilatation of RER (Fig. 2B). Also, some
degenerated neutrophiles with rariﬁed cytoplasm were seen
and an apoptotic change was observed in some cells in which
the nuclear chromatin became electron dense and took the
halfmoon shaped nucleus (Fig. 2C). In group III mature lym-
phocytes with chromatin tended to be clumped around the
periphery, as well as a healthy plasma cell with normal RER
was noticed (Fig. 2D). In group IV, many degenerated spleno-cytes with multiple cytoplasmic vacuoles were seen. Apoptotic
cells with condensed and shrinking nuclei were also observed
(Fig. 2E). In group V, some mature and normal lymphocytes
and a plasma cell were seen as well as some lymphocytes had
electron dense nuclear chromatin (Fig. 2F).
Immunohistochemical observation
Immunohistochemical examination of CD3+T cells in the
spleen of the different groups clariﬁed that, CD3+ T cells took
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Fig. 2 Transmission electron photomicrograph of the spleen from rats in: (A) group I showing many healthy looking splenocyte:
lymphocytes (asterisk), plasma cell (P) and part of dendritic cell (arrow) with cell surface processes elongated between splenocytes
(headarrow). (B) Group II showing: two degenerated plasma cells, the left one appears as ghost (P1), the right one appears with marked
dilatation of RER (P2). (C) Group II showing: degenerated neutrophil (arrow) with rariﬁed cytoplasm. Apoptotic change is observed in
one cell in the form of halfmoon shaped nucleus (arrowhead), (D) group III showing mature lymphocytes with chromatin tended to be
clumped around the periphery (asterisk), small healthy plasma cell (P) with normal RER (arrowhead) and erythrocytes (R). Condensed
nucleus is observed (arrow). (E) Group IV showing degenerated splenocyte (arrow) with multiple cytoplasmic vacuoles, some of them are
large (v). Some apoptotic cells (arrowhead) with condensed and shrinking nuclei are observed, (F) group V showing mature lymphocyte
(asterisk) and plasma cell (P). Lymphocyte with electron dense nuclear chromatin is observed (arrow). Urinyle citrate lead acetate stain.
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number in the periarterial sheath of the white pulp of group
I (Fig. 3A). In group II, there were minimal number of
CD3+ T cells in the periarterial sheath (Fig. 3B), while in
group III there are moderate number of CD3+ T cells in the
periarterial sheath (Fig. 3C). In group IV, the number of
CD3+ T cells was decreased (Fig. 3D), while in group V there
is more density of CD3+ T cells in the periarterial sheath of
the white pulp (Fig. 3E).Cytokines and immunoglobulins
The plasma level of IL-2 was signiﬁcantly decreased
(P< 0.05) in group II and III compared to the control group
and signiﬁcantly increased (P< 0.05) in rats of group III com-
pared to the rats of group II (Fig. 4). Also, ﬁg. 4 shows that,
IL-6 was signiﬁcantly decreased (P < 0.05) in rats of groups
II and IV compared to the control group. However, it signiﬁ-
cantly increased (P< 0.05) in rats of group III. INF-c was
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50 μm 50 μm 
50 μm
Fig. 3 Spleen of rat showing CD3+ cells which take cytoplasmic blackish discoloration. (A) In group I, there are high number of
CD3+T cells in the periarterial sheath of the white pulp, (B) in group II, there are minimal number of CD3+ T cells in the periarterial
sheath of the white pulp, (C) in group III, there are moderate number of CD3+ T cells in the periarterial sheath of the white pulp, (D) in
group IV, the number of CD3+ T cells in the periarterial sheath of the white pulp decreased, (E) in group V, there is more density of CD3+
T cells in the periarterial sheath of the white pulp. Immunohistochemical technique using Labeled Streptavidin- Biotin immunoperoxidase
technique.
248 Hossam El-Din M. Omar et al.signiﬁcantly decreased (P> 0.05) in all treated groups com-
pared to the control group, however, it signiﬁcantly increased
(P< 0.05) in rats of group V compared to the rats of group IV
(Fig. 4). Fig. 5 shows the levels of IgG and IgM in plasma of
control and the different treated groups. It clearly shows that
both IgG and IgM decreased in all CsA treated groups com-
pared to the control group and fucoidan treatment botched
to restore these decreases.
Oxidative stress makers
Table 1 shows the oxidative stress biomarkers in the spleen
tissues of control and different treated groups. All the treated
groups showed a signiﬁcant increase in LPO compared to theuntreated control group. Nitric oxide showed a non-signiﬁ-
cant change in rats of groups II and III compared to the
control group. However, it was signiﬁcantly increased
(P< 0.01) in rats of group IV compared to the control
group and signiﬁcantly decreased (P< 0.001) in rats of
group V compared to rats of group IV. GSH level was in-
creased only in rats of groups II and III when it was com-
pared to that of the control group. Vit C content and the
activities of CAT and G6PDH did not show any signiﬁcant
changes between the treated groups and control and between
the treated groups. However, SOD activity was signiﬁcantly
decreased (P< 0.001) in rats of group II compared to the
control and increased (P<.0.05) in rats of group III and V
compared to the group II.
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Fig. 4 Effect of treatment with CsA and fucoidan on IL-2, IL-6 and IFN- c levels in the plasma of male albino rats. a = signiﬁcance
difference between group I and different treated groups. b = signiﬁcance difference between group II and other treated groups.
c = signiﬁcance difference between group IV and other treated groups.
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Fig. 5 Effect of treatment with CsA and fucoidan on IgM and
IgG levels in plasma of male albino rats. a = signiﬁcance
difference between group I and different treated groups.
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In the present work, semithin and transmission electron micro-
scopic studies of the spleen in rats treated with CsA revealed
degeneration of lymphocytes, plasma cells and neutrophils.
The observed degenerative changes in the neutrophils mightreﬂect the suppressive effect that was exerted by an indirect ef-
fect of CsA through its effect on T cells. Several authors sup-
ported this observation and reported that, calcineurin might be
involved in the inhibitory effect of CsA on neutrophils through
the impairment of gene up-regulation which is regulated by nu-
clear factor of activated T cells (Greenblatt et al., 2010). In
addition, CsA binds to all human leucocytes and might bind
granulocytes and cells of the mononuclear phagocyte system
more than lymphocytes (Garcia et al., 2000).
CsA is accumulated in cell membranes because it is a highly
lipophilic drug (Kapturczak et al., 2004). Moreover, CsA in-
duces ER stress and cell damage in tubular cells which can
contribute to dedifferentiation and cell death in the kidney
(Pallet et al., 2008a,b) through induction pro-apoptotic pro-
teins (Han et al., 2008). Endoplasmic reticulum (ER) stress,
which is induced by the accumulation of unfolded proteins
in the ER under physiological and pathological conditions,
triggers unfolded protein response to reestablish normal ER
function. When adaptation fails and ER stress is prolonged,
the cell triggers suicide programs (Dickhout and Krepinsky,
2009). So, the previous studies can explain the degenerated
changes that occurred in RER of plasma cell in rats treated
with CsA in the present study. On the other hand, the observed
dilatations in RER of plasma cells may be explained by the
immunoglobulin (Ig) accumulation inside RER and by an in-
crease in their immunological activity (Sohal and Weidman,
1978). However, dilatation of the RER in several cell types
indicates some defects in the progress of secretory material
(Shiner, 1973).
In the present study, the degenerated changes, induced by
CsA, in lymphocytes and other splenocytes were observed
more than the apoptotic changes. In this aspect, maintenance
Table 1 Oxidative stress parameters (M ± SE) in the spleen tissue of control and different treated groups.
Biomarkers Groups
Group I
(Control I)
Group II
(CsA, 25 mg/kg b.w)
Group III
(CsA, 25 mg/kg b.w
plus fucoidan
5 mg/kg b.w)
Group IV
(CsA, 50 mg/kg b.w)
Group V
(CsA, 5 0 mg/kg
b.w plus fucoidan
10 mg/kg b.w)
Lipid peroxidation (nmol/mg protein) 2.417 ± 0.018 3.245 ± 0.238a* 3.045 ± .139a* 3.664 ± 0.139a*** 3.140 ± 0.224a*
Nitric oxide (nmol/mg protein) 0.294 ± 0.017 0.266 ± 0.039 0.224 ± 0.012 0.410 ± 0.020 a** 0.262 ± 0.012c***
Glutathione (lg/mg protein) 1.402 ± 0.059 1.340 ± 0.0656 1.814± 0.122 a**b** 1.435± 0.074 1.464± 0.072
Vitamin C (lg/mg protein) 2.105± 0.088 2.030± 0.117 2.166± 0.097 2.287± 0.148 2.233± 0.223
Superoxide dismutase (U/min/mg protein) 0.917± 0.058 0.469± 0.053a*** 0.706± 0.025b* 0.660± 0.106 0.723± 0.071
Catalase (U/min/mg protein) 11.680± 0.839 8.889± 1.054 11.430± 0.645 12.030± 1.246 13.030± 0.905
Glucose 6 phosphate dehydrogenase
(U/min/mg protein)
0.332± 0.081 0.318± 0.075 0.544± 0.101 0.231± 0.030 0.300± 0.091
a Signiﬁcance difference between group I and different treated groups.
b Signiﬁcance difference between group II and other treated groups.
c signiﬁcance difference between group IV and other treated groups.
* P< 0.05.
** P< 0.01.
*** P < 0.001.
250 Hossam El-Din M. Omar et al.of mitochondrial integrity is critical in apoptosis inhibition. In
addition, cytochrome-c is generally conﬁned to mitochondria,
however its release into the cytosol upon rupture of the mito-
chondrial membrane results in a cascade of caspase activation
(Srinivasula et al., 2000). Doonan and Cotter (2004) conﬁrmed
the critical roles of CsA in preventing apoptosis by blocking
the release of cytochrome-c. However, apoptosis in hippocam-
pal neurons after CsA treatment was suggested as a result of
calcium overload (Kaminska et al., 2001). Furthermore, higher
cytosolic Ca2+ level in activated lymphocytes increases their
susceptibility to oxidative stress which induced cell death in a
mechanism involving the participation of mitochondrial per-
meability transition (Degasperi et al., 2008).
In the present study, fucoidan treatment ameliorated the
degenerated changes in splenocytes induced by CsA. It is well
known that, fucoidan enhances various immune responses in
the spleen lymphocytes and peripheral macrophages and in-
creased T and B lymphocytes during endotoxemia (Choi
et al., 2005; Ko and Joo, 2011). Moreover, fucoidan encour-
ages cell regeneration (Irhimeh et al., 2007) and apoptosis,
and removes degenerated and abnormal cells (Kim et al.,
2010).
The expression of CD3+ after CsA treatment was reduced
in the present study. However, this reduction was ameliorated
after fucoidan treatment. This decrease in CD3+ T cell by
CsA is compatible with previous studies carried out by Fang
et al. (2006) and Song et al. (2010) who found that, CsA signif-
icantly decreased the% of CD3+ T cells in the spleen with a
concomitant increase of CD19+ B cell. Also, when Con A,
lymphocyte proliferation inducer, was administrated to rat in-
jected with CsA, the spleen tissue showed a marked reduction
of T cell proliferation (Varalakshmi et al., 2008). Moreover, T
lymphocyte number in the dermis was decreased signiﬁcantly
by CsA treatment (Baker et al., 1989). Choi et al., 2005 found
the cytotoxic effect of mouse spleen lymphocytes on tumor
cells after culture with fucoidan. Moreover, fucoidan is highly
effective in mobilizing stem cells into the peripheral circulation
in baboons and mice (Irhimeh et al., 2007). The mechanism of
stem cell mobilization is related with the inhibition of selectinbinding and with the ability of fucoidan binding to stromal-de-
rived factor-1 (SDF-1). So, fucoidan can increase the number
of stem cells, blood cells and SDF-1 level in plasma (Sweeney
et al., 2000; Fermas et al., 2008).
CsA inhibits T-cell activation largely by blocked IL-2 pro-
duction that is seen in the present study. Fitzpatrick et al.
(1994) found the inhibitory effect of CsA on the secretion of
IL-2 and other growth-promoting lymphokines prevent the
activation and proliferation of lymphocytes and other immune
cells. Also, CsA inhibited IL-2 responsiveness through inhib-
ited IL-2R (Donnan and Cotter, 2004). However, IL-2 and
IL-4 in combination were able to reverse the immunosuppres-
sive activity of CsA (Fitzpatrick et al., 1994). Moreover, the
inhibition of CsA calcineurin-NFAT pathway leads to toxic
changes and immunosuppressive effects (Krejcia et al., 2010).
Also, CsA preventive events occurring during the G1 phase
of growth are necessary for non-motile lymphocytes to acquire
locomotor capacity (Wilkinson and Higgins, 1987).
In the present study, IFN-c level was signiﬁcantly deceased
in all CsA treated rats with or without fucoidan compared to
control, whereas it was increased in rats treated with fucoidan
in recovery period after CsA treatment. It has been found that,
CsA signiﬁcantly inhibited IFN-c level which was enhanced in
Con A stimulated spleen cells (Song et al., 2010). Also, the
immunosuppressive effect of CsA on Mycobacterium bovis
BCG-infected mice was expressed by inhibiting the develop-
ment of effector T cells, which then caused a reduction in
the production of IFN- c (Takashima and Collins, 1987).
Fucoidan signiﬁcantly enhanced the cytolytic activity of NK
cells and increased IFN-c production by T cells (Maruyama
et al., 2003). However, fucoidan suppressed TNF-a- and
IFN-c-induced NO production and iNOS expression in neuro-
degenerative disorders (Do et al., 2010). In the present study,
IL-6 level was decreased in plasma of rats treated with CsA,
whereas the treatment with fucoidan reversed this decrease.
It is known that, IL-6 is secreted by monocytes, macrophages,
lymphocytes and epithelial cells (Hirano et al., 1990). CsA
inhibited IL-2, IL-6, and IFN- c production by CD4+ T lym-
phocytes which stimulated via the T cell antigen receptor
The immunomodulating and antioxidant activity of fucoidan on the splenic tissue of rats treated with cyclosporine A 251pathway (Thomson, 1992). In macrophage, IL-6 production
and other speciﬁc defense functions are more susceptible to
the action of CsA, whereas the phagocytic activity of macro-
phage is resistant to CsA (Mrowietz and Christophers, 1988;
Losa Garcı´a, 1996). Fucoidan could activate murine peritoneal
macrophages that resulted in an increase in the production of
TNF-a and IL-6 (Choi et al., 2005). However, fucoidan
improved murine chronic colitis by down-regulating the syn-
thesis of IL-6 in the colonic epithelial cells (Matsumoto
et al., 2004).
In the present study, the plasma levels of IgM and IgG were
decreased in all treated groups compared with the control
group. In this aspect, the growth and differentiation of B lym-
phocytes were decreased due to the inhibitory effect of CsA on
some cytokine production by stimulated CD4+ T lympho-
cytes (Thomson, 1992). Furthermore, CsA inhibited IgG and
IgA production in T depleted cultures, but had little effect
on IgM or IgD (Pereira et al., 1983). Similar ﬁndings on T-
independent B cell responses have been described in murine
systems (Kunkl and Klaus, 1980). Moreover, CsA decreases
Ig production in cultures from normal healthy adults, without
prior immunity (Pereira et al., 1983). Rapamycin, a more po-
tent in vitro immunosuppressant of B lymphocytes than CsA,
did not stimulate either the proliferation or antibody produc-
tion by pre-activated B cells (Kim et al., 1994) and did not pre-
vent Ig isotype switching that was observed with CsA
(Thomson et al., 1993). In the present study, fucoidan treat-
ment decreased plasma levels of IgM and IgG in all treated
groups, whereas low dose of CsA caused the most inhibition
of IgG level. In this topic, Zhang et al. (2003) found that, fuco-
idan treatment reduced IgG and IgM levels in delayed-type
hypersensitivity reaction and suppressed the increase of the to-
tal IgG through Ig class switching inhibition in culture of
mouse splenocytes and B cells. Similarly, fucoidan suppressed
IgE induction by inhibited Ig class-switching to IgE in human
B cells (Iwamoto et al., 2011). Furthermore, fucoidan inhibited
Ig class-switching to IgE in murine B cells through its inhibi-
tory effect on NF-jB p52-mediated pathway (Oomizu et al.,
2006).
Oxidative stress has been proposed as a causative factor in
CsA-induced renal, hepatic and cardiovascular toxicity (Walk-
er et al., 1990; Suleymanlar et al., 1994; Rezzani et al., 2005;
Nagaraja et al., 2009). In the present study, TBARS content
in the spleen tissue was signiﬁcantly increased in rats treated
with CsA, indicating lipid peroxide radical and oxidative stress
generation. Similar result was obtained by Mohamadin et al.
(2005) in kidneys of rats treated with CsA. The generation of
free radicals may be directly from CsA or during its metabo-
lism by the CYP 450 system (Ahmed et al., 1995). Consistent
with this possibility, CsA has been reported to increase lipid
peroxidation in isolated hepatic microsomes, the major meta-
bolic site for CsA (Inselmann et al., 1990). This observation
suggested that, CsA or its metabolites produced free radical
species that attacked lipid components which resulted in lipid
peroxidation. The increase of lipid hydroperoxide production
and the decrease in the total antioxidants with CsA treatment
conﬁrm the role of oxidative stress in CsA induced organ tox-
icity (Nagaraja et al., 2009). Fucoidan treatment failed to de-
crease the elevation in TBARS content, whereas quercetin,
vitamin E and bioﬂavonoid apigenin decreased the lipid perox-
idation-induced by CsA (Chen et al., 2001; Nagaraja et al.,
2009).The ability of CsA to inhibit macrophage-dependent NO
synthesis involves both inhibition of transcription of the iNOS
gene and the enzyme activity (Conde et al., 1995; Hattori and
Nakanishi, 1995). In the present study, NO was signiﬁcantly
increased in the spleen tissue of rats treated with a high dose
of CsA and not changed by low dose. In this topic, CsA ex-
erted a moderate inhibition of NO synthesis (Liebermann
et al., 1995; Wang et al., 1997). Hortelano et al. (1999) sug-
gested that, CsA interacts with several pro-apoptotic as well
as they suggested that, viability of activated macrophages is
improved in the course of immunosuppressive therapy (Horte-
lano et al., 1999). Fucoidan treatment restored the increases in
NO content in the spleen tissue. Similarly, apigenin inhibited
the production of NO by suppressing the iNOS expression
and inhibiting the iNOS activity (Ha et al., 2008).
The implication of oxidative stress in CsA spleen toxicity
was strengthened by the marked observed histopathological
changes in the spleen. Endogenous antioxidants are responsi-
ble for neutralizing the free radical-induced oxidative damage.
In the present study, SOD activity and GSH content were al-
tered by CsA treatment, however, CAT and G6PD did not
show any signiﬁcant changes in all the treated rats. In this as-
pect, CsA administration signiﬁcantly decreased the activity of
antioxidant enzymes in CsA-induced nephrotoxicity (Moham-
adin et al., 2005). Moreover, antioxidant-rich diets protect
from diseases involved in oxidative damage (Bordoni et al.,
2002). In conclusion, modulating the antioxidants’ defense
mechanisms by chemopreventive agents has become a part of
many therapeutic strategies and in the present study; co-sup-
plementation of fucoidan with CsA signiﬁcantly restored the
adverse toxicity in the spleen tissue of CsA-treated rats.Acknowledgment
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